Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.37
Jul. 31, 2025 16:00:00- Change -0.0325 (-8.16378%)
- Volume 6,201,553
- Today's Open 0.3998
- Previous Close 0.3981
- Today's High 0.3998
- Today's Low 0.3403
- 52 Week High 4.3
- 52 Week Low 0.34